Cynthia Owusu

Cynthia Owusu

Auto-generated profile, based on publicly available information

Cynthia Owusu

Division of Hematology/Oncology Department of Medicine Case Western Reserve University School of Medicine Cleveland Ohio

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
COCynthia Owusu
Cynthia Owusu
DBDiana S.M. Buist
Diana S.M. Buist
TFTerry S. Field
Terry S. Field
TLTimothy L. Lash
Timothy L. Lash
STSoe Soe Thwin
Soe Soe Thwin
RSRebecca A. Silliman
Rebecca A. Silliman
Purpose: Five years of adjuvant tamoxifen therapy for estrogen receptor (ER) –positive breast cancer is more effective than 2 years of use. However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer. Patients and Methods: Within six health care delivery systems, we identified women ≥ 65 years old diagnosed with stage I to IIB ER-positive or indeterminant breast cancer between 1990 and 1994 who had filled a prescription for adjuvant tamoxifen. We observed them for 5 years after initial tamoxifen prescription. We used automated pharmacy records to validate tamoxifen prescription information abstracted from medical records. The primary end point was tamoxifen discontinuation, operationalized as ever discontinuing tamoxifen during 5 years of follow-up. We used Cox proportional hazards to identify predictors of tamoxifen discontinuation. Results: Of 961 women who were prescribed tamoxifen, 49% discontinued tamoxifen before the completion of 5 years. Discontinuers were more likely to be aged 75 to less than 80 years (v < 70 years; hazard ratio [HR] = 1.41; 95% CI, 1.06 to 1.87), be aged ≥ 80 years (HR = 2.02; 95% CI, 1.53 to 2.66), have an increase in Charlson Comorbidity Index at 3 years from diagnosis (HR = 1.52; 95% CI, 1.18 to 1.95), have an increase in the number of cardiopulmonary comorbidities at 3 years (HR = 1.75; 95% CI, 1.34 to 2.28), have indeterminant ER status (v ER-positive status; HR = 1.36; 95% CI, 1.00 to 1.85), and have received breast-conserving surgery (BCS) without radiotherapy (v mastectomy; HR = 1.62; 95% CI, 1.18 to 2.22). Conclusion: Attention to nonadherence among older women at risk of discontinuation, particularly those receiving BCS without radiotherapy, might improve breast cancer outcomes for these women.

1 July 2012 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
GPGopi K. Prithviraj
Gopi K. Prithviraj
SKSiran Koroukian
Siran Koroukian
SMSeunghee Margevicius
Seunghee Margevicius
NBNathan A. Berger
Nathan A. Berger
RBRakesh Bagai
Rakesh Bagai
COCynthia Owusu
Cynthia Owusu

1 April 2011 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
COCynthia Owusu
Cynthia Owusu
SKSiran Koroukian
Siran Koroukian
MSMark Schluchter
Mark Schluchter
PBPaul Bakaki
Paul Bakaki
NBNathan A. Berger
Nathan A. Berger

1 September 2017 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
COCynthia Owusu
Cynthia Owusu
SMSeunghee Margevicius
Seunghee Margevicius
MSMark Schluchter
Mark Schluchter
SKSiran Koroukian
Siran Koroukian
NBNathan A. Berger
Nathan A. Berger

24 May 2018 in Cancer
Verified
Journal Article
Closed access
PDF file
ESEnrique Soto-Pérez-De-Celis
Enrique Soto-Pérez-De-Celis
CSCan‐Lan Sun
Can‐Lan Sun
WTWilliam P. Tew
William P. Tew
SMSupriya Gupta Mohile
Supriya Gupta Mohile
AGAjeet Gajra
Ajeet Gajra
AHArti Hurria
Arti Hurria

1 May 2018 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
COCynthia Owusu
Cynthia Owusu
EAElizabeth Antognoli
Elizabeth Antognoli
Nora NockNora Nock
Nora Nock
PHPaul Hergenroeder
Paul Hergenroeder
KAKristina Austin
Kristina Austin
SFSusan Flocke
Susan Flocke